Successful percutaneous aortic valve implantation via a stenotic left subclavian artery access.

19:12 EST 21st November 2014 | BioPortfolio

Summary of "Successful percutaneous aortic valve implantation via a stenotic left subclavian artery access."

Severe aortic valve stenosis may be tackled with percutaneous aortic valve replacement instead of surgical replacement. At present, two CE marked prosthetic valves are available. The CoreValve ReValving System is primarily designed to be introduced transfemorally, while implantation via subclavian arteries has been described in cases of unsuitable femoral access. However, this route has been used when subclavian artery is free of disease. In this case report we describe a successful CoreValve ReValving System implantation via a diseased and tortuous left subclavian artery after predilatation balloon angioplasty. The prosthesis was then advanced in the native aortic valve, deployed, and successfully implanted. Techniques and manipulations are provided.

Affiliation

, 113 Astypaleas Street, Anoixi, Attiki, 14569, Greece, vavouran@otenet.gr.

Journal Details

This article was published in the following journal.

Name: Heart and vessels
ISSN: 1615-2573
Pages: 359-62

Links

PubMed Articles [9397 Associated PubMed Articles listed on BioPortfolio]

Symptomatic stenosis of left subclavian artery from Kommerell's diverticulum.

Patients with a right aortic arch frequently develop an aneurysm at the origin of the left subclavian artery, called Kommerell's diverticulum; it is a remnant of the left fourth aortic arch. These var...

Direct aortic transcatheter valve implantation in a porcelain aorta.

Transcatheter aortic valve implantation has been designed to treat elderly patients with severe aortic stenosis at high risk for surgery, and is generally performed retrogradely with vascular access. ...

Successful transcatheter aortic valve implantation in a Hodgkin lymphoma patient with severe aortic stenosis.

Transcatheter aortic valve implantation (TAVI) has emerged as an acceptable treatment modality for patients with severe aortic stenosis (AS) who are deemed unsuitable for conventional surgical aortic ...

Mechanical Aortic Valve-on-Valve Replacement in Previous Bentall Procedure: An Alternate Technique.

Acute aortic valve regurgitation due to thrombosed prosthetic valve can present as a surgical emergency. This article reports a successful and unusual management of a young pregnant female patient who...

Successful Use of a Left Ventricular Apical Access and Closure Device for Second-Generation Transapical Aortic Valve Implantation.

Background Transcatheter aortic valve implantation (TAVI) has become routine for the treatment of high-risk patients with aortic stenosis. We assessed safety and feasibility of a left ventricular ap...

Clinical Trials [2031 Associated Clinical Trials listed on BioPortfolio]

Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease

A prospective single arm study evaluating feasibility and safety of a catheter-based transapical implantation of the Ventor Embracer™ aortic valve bioprosthesis in patients with severe a...

CoreValve® System Australia/New Zealand Clinical Study

To evaluate the performance, efficacy and safety of the percutaneous implantation of the CoreValve® prosthetic aortic valve in patients with severe symptomatic native aortic valve stenosi...

Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis

The objective of the RADAR trial is to determine the impact of External Beam Radiation Therapy (EBRT) on aortic valve restenosis following successful percutaneous balloon aortic valvulopla...

Medtronic CoreValve REDO Study

The proposed investigation is a prospective, multicenter, non-randomized study to evaluate the immediate benefits (at discharge and at 30 days) in terms of performance and safety of the im...

Minimally Invasive Aortic Valve Replacement Versus Conventional Aortic Valve Replacement. a Long Term Registry

The aim of the present study is to assess in a "real life" caselist the outcome of three different surgical approches for isolated aortic valve surgery in terms of surgery times, morbidity...

Medical and Biotech [MESH] Definitions

The downward displacement of the cuspal or pointed end of the trileaflet AORTIC VALVE causing misalignment of the cusps. Severe valve distortion can cause leakage and allow the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to aortic regurgitation.

Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).

A type of constriction that is caused by the presence of a fibrous ring (discrete type) below the AORTIC VALVE, anywhere between the aortic valve and the MITRAL VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.

A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.

The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle.

Search BioPortfolio:
Loading